HIGHLIGHTS
- who: Julius Lindblom from the Oregon Health and Science University, United States have published the research work: EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate whether experience of EQ-5D-3L FHS after therapy for active SLE is associated with deceleration of organ damage accrual in a diverse SLE population deriving from open-label studies of belimumab. Associations between patientreported HRQoL experience and SDI increase over time have not been reported . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.